Mefloquine
Edina Avdic, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Treatment of mild to moderate acute malaria (P. falciparum and P. vivax) caused by chloroquine-resistant, chloroquine-susceptible and multiple-drug-resistant (including sulfadoxine and pyrimethamine-resistant) strains
- Malaria (P. falciparum and P. vivax) prophylaxis including prophylaxis of chloroquine-resistant strains of P. falciparum.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved